(MENAFN- P&S Intelligence) A recent innovation in biomedical engineering, the organ-on-chip technology helps researchers overcome the limitations and constraints of the traditional two-dimensional cell culture processes and methodologies by enabling the development of models that mimic the 3D (three-dimensional) arrangement of various cell types in the human body more accurately. With the growing incidence of chronic diseases, the requirement for advanced treatment methods is rising rapidly. This is pushing up the requirement for alternatives to animal models in R&D (research and development).
Apart from pharmaceutical companies, many government agencies are also making huge investments in organ-on-chip research activities. For example, the National Center for Advancing Translational Sciences (NCATS) provided a research grant worth $2 million to Emulate, Inc. in July 2017. The grant was provided for using Emulate, Inc.’s human Brain-Chip system and developing a fully-automated research platform, wherein, experiments would be conducted on the International Space Station. Similarly, many other organizations are investing huge amounts of money for promoting organ-on-chip research.
Hence, with the rising adoption of this technology in medical research, the global organ-on-chip market will exhibit huge expansion in the future years. Based on the type of organ cells, the market is divided into lung-on-chip, liver-on-chip, heart-on-chip, kidney-on-chip, brain-on-chip, and intestine-on-chip categories. Out of these, the liver-on-chip category recorded considerably high growth in the market during the last few years, primarily because of the high incidence of chronic liver diseases and the rapid advancements in liver treatment research.
Geographically, the Asia-Pacific (APAC) organ-on-chip market will be very prosperous in the upcoming years, as per the forecast of P&S Intelligence, a market research company based in India. The market growth will be driven by the rising healthcare expenditure, the increasing initiatives being launched by the governments of regional countries, surging investments being made in healthcare research, and the growing incorporation of advanced technologies in healthcare operations in the region.
MENAFN09082021005304011875ID1102591176
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.